APRE - Aprea Therapeutics Inc
IEX Last Trade
3.38
0.051 1.521%
Share volume: 1,620
Last Updated: Fri 30 Aug 2024 09:19:29 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.33
0.05
1.54%
Fundamental analysis
23%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
20%
Performance
5 Days
-2.31%
1 Month
-9.89%
3 Months
-25.57%
6 Months
-52.38%
1 Year
-8.08%
2 Year
-78.43%
Key data
Stock price
$3.38
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.20 - $8.85
52 WEEK CHANGE
-$0.09
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 3
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 3
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
annan naturvetenskaplig och teknisk forskning och utveckling
Recent news